Ocutrx Vision Technologies Appoints Dr. Linda Lam as Chief Scientific and Strategy Officer

January 24, 2019

Ocutrx Vision Technologies, LLC, a California-based developer of augmented reality (AR) glasses, today announced that Dr. Linda Lam, MD, MBA, joined the company’s executive management team in the role of chief scientific and strategy officer. Currently an associate professor of Ophthalmology and vice chair of Satellite Clinical Affairs at the USC Keck School of Medicine, Dr. Lam will lead the development and oversight of the scientific, technological and research operations currently underway at Ocutrx. In this position, she will guide new technology development as well as help align current and future R&D efforts with organizational priorities, industry trends and growth opportunities.

"We are pleased to welcome Dr. Lam into the management team at Ocutrx. Dr. Lam has a track record as an outstanding clinician, innovator and educator," said Michael H. Freeman, CEO/CTO. "Her commitment to innovation, scholarly research and improved patient outcomes is an excellent fit with Ocutrx’s flagship product, the Oculenz augmented reality glasses for low vision patients among other applications. We are confident the leadership for science and strategy is being placed into very experienced and capable hands." 

Dr. Lam brings a deep expertise in complex medical and surgical vitreoretinal cases to Ocutrx. Her unique skill set also extends to clinical operations and strategy, research in macular degeneration, medical devices, artificial intelligence research and vision rehabilitation. In addition to her work at the USC Keck School of Medicine, Dr. Lam is also an executive board member of the Braille Institute of America and member of the board of low vision rehabilitation for the American Academy of Ophthalmology.

“The work Ocutrx is doing to advance augmented reality products and broader medical technology in the augmented reality space is revolutionary and broadly applicable across multiple demographics, industries and levels of visual impairments,” said Dr. Lam. “I’m thrilled with the opportunity to contribute to the groundbreaking work at Ocutrx and I can’t wait to share with the medical community some of the exciting progress we have in store for 2019.

To learn more about Ocutrx and the company’s groundbreaking AR wear and AR technology, please visit http://www.oculenz.com/

 

See the latest posts on our homepage


Share

Topic Area: Press Release


Recent Posts
Recent Posts

New alarms that whistle and sing are designed to lessen hospital noise


Efforts are underway to make alarms quieter and design systems of visual cues — like interactive screens that look like paintings

7/19/2019

Blog

When specifying boilers, design details matter


Installing a boiler system is a significant investment requiring thoughtful consideration to ensure heating comfort, reliability and efficiency

7/19/2019

$1.5 billion Philadelphia healthcare pavilion project using lean practices, offsite fabrication


The project is using prefabrication for time-intensive construction like mechanical, plumbing and drywall work

7/19/2019

Lighting can support healthier patient rooms


Advanced lighting design can improve patient and visitor outcomes and comfort and staff productivity

7/19/2019

Focus: Cybersecurity

Tips for hiring healthcare cybersecurity pros


Cybersecurity requires people from all backgrounds and majors

7/19/2019





Post Comment




FREE
NEWSLETTER

News & Updates • Webcast Alerts • Building Technologies

All fields are required.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.